Correlation between cytidine deaminase (CDA) genotype and clinical outcome/toxicity in advanced non-small cell lung cancer (NSCLC) patients treated with gemcitabine/platinum-based chemotherapy / Tibaldi C; Giovannetti E; Tiseo M; Danesi R; Leon LG; Bartolotti M; D'Incecco A; Erozenci AL; Falcone A; Peters GJ; Ardizzoni A. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - STAMPA. - 4:9(2009), pp. S553-S553.
Correlation between cytidine deaminase (CDA) genotype and clinical outcome/toxicity in advanced non-small cell lung cancer (NSCLC) patients treated with gemcitabine/platinum-based chemotherapy
ARDIZZONI, ANDREA
2009
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.